Science
Naveen Pemmaraju
youtube.com

Naveen Pemmaraju: Novel Tasquinimod-Based Combos in Advanced MPNs

Naveen Pemmaraju, Director of Leukemia-Cancer Network, Executive Director of Cancer Medicine, Director of BPDCN at the Department of Leukemia, and Professor at the Department of Leukemia at MD Anderson Cancer Center, shared a post on LinkedIn about a paper he co-authored with colleagues published in Blood Advances:

“I am pleased to share our MPN group’s brand new collaborative original work just out in Blood Advances, led by Dr Bhalla, highlighting novel pre-clinical work in Tasquinimod-based combos in advanced MPN states.”

Title: Preclinical efficacy of tasquinimod-based combinations in advanced myeloproliferative neoplasms (MPN) in blastic phase

Authors: Warren Fiskus, Lucia Masarova, Christopher P Mill, Christine Birdwell, Kaberi Das, Hanxi Hou, John A Davis, Antrix Jain, Anna Malovannaya, Taghi Manshouri, Andrew Dunbar, Surbhi Sharma, Tapan M. Kadia, Courtney D. DiNardo, Prithviraj Bose, Naveen Pemmaraju, Sanam Loghavi, Xiaoping Su, Raajit K. Rampal, Marie Törngren, Kapil N Bhalla

You can read the Full Article on Blood Advances.

Naveen Pemmaraju: Novel Tasquinimod-Based Combos in Advanced MPNs

More posts featuring Naveen Pemmaraju.

Andrew Dunbar Anna Malovannaya Antrix Jain blood advances cancer Christine Birdwell Christopher P Mill Courtney D. DiNardo Hanxi Hou John A. Davis Kaberi Das Kapil N. Bhalla Lucia Masarova Marie Törngren MPN myeloproliferative neoplasms Naveen Pemmaraju OncoDaily Oncology Prithviraj Bose Raajit K. Rampal Sanam Loghavi Surbhi Sharma Taghi Manshouri Tapan M. Kadia Tasquinimod Warren Fiskus Xiaoping Su